Device Trial Radar · NCT03035643
DARTS I Feasibility Study
Last checked: Nov 21, 2026Latest source record: Aug 20, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Mar 5, 2017
Primary completion
Aug 21, 2019
Study completion Mar 19, 2024
Sponsor
- Lead sponsor
- Ascyrus Medical LLC.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Artivion Inc.
- First posted
- Jan 30, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to investigate the feasibility and clinical benefits of the AMDS to treat patients with acute DeBakey type I dissections and/or intramural hematomas (IMH) involving the ascending aorta and aortic arch through open surgical repair.
Conditions
- Aortic Dissection
- Intramural Hematoma
Interventions
AMDSDevice
The device will be implanted during an already planned surgical intervention for aortic dissection repair. The participant will be observed and data gathered during the surgery and routine standard of care follow up visits.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with device-related mortalityTime frame: Early (within 30 days)
5 more outcomes with a free account
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Mazankowski Alberta Heart Institute, University of Alberta
Edmonton, Alberta, Canada
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.